Renowned Retinal Surgeon and Medical Entrepreneur, Sunil Gupta, MD, Joins Nanoscope Board of Directors
DALLAS, Nov. 7, 2024 /PRNewswire/ — Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal... Read more.
Canadian Solar Schedules Third Quarter 2024 Earnings Conference Call for December 5
GUELPH, ON, Nov. 7, 2024 /PRNewswire/ — Canadian Solar Inc. (“the Company”, “Canadian Solar”) (NASDAQ: CSIQ) today announced that it... Read more.
Evogene Schedules Third Quarter 2024 Financial Results Release
Zoom conference call scheduled for November 21, 2024, 9:00 AM ET REHOVOT, Israel, Nov. 7, 2024 /PRNewswire/ — Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a... Read more.
CB&I Awarded Contract by Viva Energy for its Newport Terminal Tank Replacement Project Located in Melbourne, Australia
HOUSTON, Nov. 7, 2024 /PRNewswire/ — CB&I, a wholly owned unrestricted subsidiary of McDermott, has been awarded a sizeable* lump sum contract by Viva... Read more.
ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine’s Center for Cell and Gene Therapy
ST. PAUL, Minn., Nov. 7, 2024 /PRNewswire/ — ScaleReady, in collaboration with Wilson Wolf Manufacturing and Bio-Techne Corporation and CellReady, has awarded... Read more.
Altair® PollEx™ for ECAD Now Available
Solution empowers engineers with advanced PCB verification tools at no cost TROY, Mich., Nov. 7, 2024 /PRNewswire/ — Altair (Nasdaq: ALTR), a global leader... Read more.
T-Neuro Pharma Welcomes Renowned Alzheimer’s Researcher Dr. Jeffrey Cummings as Chair of Scientific Advisory Board
ALBUQUERQUE, N.M., Nov. 7, 2024 /PRNewswire/ — T-Neuro Pharma, a leading biotechnology company dedicated to developing innovative therapies for neurodegenerative... Read more.
BCE reports third quarter 2024 results
This news release contains forward-looking statements. For a description of the related risk factors and assumptions, please see the section entitled “Caution... Read more.
Propel Announces Normal Course Issuer Bid
TORONTO, Nov. 7, 2024 /CNW/ – Propel Holdings Inc. (“Propel” or the “Company“) (TSX: PRL), the fintech facilitating access to credit... Read more.
Frieghtos to Present at Sidoti Virtual Investor Conference
Presentation on Wednesday, November 13th at 9:15AM ET BARCELONA, Spain, Nov. 7, 2024 /PRNewswire/ — Freightos Limited (NASDAQ: CRGO), a leading vendor-neutral... Read more.